Search: onr:"swepub:oai:DiVA.org:su-160327" >
Chitosan enhances g...
-
Dowaidar, MoatazStockholms universitet,Institutionen för biokemi och biofysik
(author)
Chitosan enhances gene delivery of oligonucleotide complexes with magnetic nanoparticles–cell-penetrating peptide
- Article/chapterEnglish2018
Publisher, publication year, extent ...
-
2018-09-17
-
SAGE Publications,2018
-
printrdacarrier
Numbers
-
LIBRIS-ID:oai:DiVA.org:su-160327
-
https://urn.kb.se/resolve?urn=urn:nbn:se:su:diva-160327URI
-
https://doi.org/10.1177/0885328218796623DOI
Supplementary language notes
-
Language:English
-
Summary in:English
Part of subdatabase
Classification
-
Subject category:ref swepub-contenttype
-
Subject category:art swepub-publicationtype
Notes
-
Gene-based therapies, including the delivery of oligonucleotides, offer promising methods for the treatment of cancer cells. However, they have various limitations including low efficiency. Herein, cell-penetrating peptides (CPPs)-conjugated chitosan-modified iron oxide magnetic nanoparticles (CPPs-CTS@MNPs) with high biocompatibility as well as high efficiency were tested for the delivery of oligonucleotides such as plasmid pGL3, splice correction oligonucleotides, and small-interfering RNA. A biocompatible nanocomposite, in which CTS@MNPs was incorporated in non-covalent complex with CPPs-oligonucleotide, is developed. Modifying the surface of magnetic nanoparticles with cationic chitosan-modified iron oxide improved the performance of magnetic nanoparticles-CPPs for oligonucleotide delivery. CPPs-CTS@MNPs complexes enhance oligonucleotide transfection compared to CPPs@MNPs or CPPs. The hydrophilic character of CTS@MNPs improves complexation with plasmid pGL3, splice correction oligonucleotides, and small-interfering RNA payload, which consequently resulted in not only strengthening the colloidal stability of the constructed complex but also improving their biocompatibility. Transfection using PF14-splice correction oligonucleotides-CTS@MNPs showed sixfold increase of the transfection compared to splice correction oligonucleotides-PF14 that showed higher transfection than the commercially available lipid-based vector Lipofectamine™ 2000. Nanoscaled CPPs-CTS@MNPs comprise a new family of biomaterials that can circumvent some of the limitations of CPPs or magnetic nanoparticles.
Subject headings and genre
Added entries (persons, corporate bodies, meetings, titles ...)
-
Abdelhamid, Hani NasserStockholms universitet,Institutionen för material- och miljökemi (MMK),Assuit University, Egypt(Swepub:su)hnass
(author)
-
Hällbrink, MattiasStockholms universitet,Institutionen för biokemi och biofysik(Swepub:su)mhall
(author)
-
Langel, ÜloStockholms universitet,Institutionen för biokemi och biofysik(Swepub:su)ulo
(author)
-
Zou, XiaodongStockholms universitet,Institutionen för material- och miljökemi (MMK)(Swepub:su)xzou
(author)
-
Stockholms universitetInstitutionen för biokemi och biofysik
(creator_code:org_t)
Related titles
-
In:Journal of biomaterials applications: SAGE Publications33:3, s. 392-4010885-32821530-8022
Internet link
Find in a library
To the university's database